Page 8 - Presentation

PSMA is “targetable” using antibodies and

small molecules

• Radiolabeled compounds for imaging

and treatment

• Investigational antibody-drug

conjugates

• Immune cell–targeted therapies

• Anti-PSMA chimeric antigen receptor (CAR)

• PSMA-directed vaccines

• Bispecifc antibodies and BiTE®(Bispecific T-

cell Engager) molecules: engage patients’

own T cells and PSMA

A Juzeniene, et al. Cancers 2021, 13(4), 779